EFSCE
AGIO icon

Enterprise Financial Services Corp (EFSC)’s Agios Pharmaceuticals AGIO Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19
Closed -$1K – 1255
2020
Q2 		$1K Buy
+19
New +$880 ﹤0.01% 1151
2016
Q1 		– Sell
-25
Closed -$2K – 1048
2015
Q4 		$2K Hold
25
– – ﹤0.01% 897
2015
Q3 		$2K Hold
25
– – ﹤0.01% 859
2015
Q2 		$3K Hold
25
– – ﹤0.01% 810
2015
Q1 		$2K Hold
25
– – ﹤0.01% 975
2014
Q4 		$3K Buy
+25
New +$2.23K ﹤0.01% 905

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s AGIO Position: Q3 2020 in Review

Enterprise Financial Services Corp (EFSC) sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 19 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in AGIO in Q4 2014 and held it in 6 quarters. The position peaked at $3K in Q2 2015. 215 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 19 Agios Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 6 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Agios Pharmaceuticals position peaked at $3K in Q2 2015.
  • 215 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2020, filed 13 Nov 2020.